Pendulum Therapeutics Launches First Medical Probiotics for Patients With Type 2 Diabetes

San Francisco, June 4, 2020 / PRNewswire /- Pendulum treatmentIs a state-of-the-art microbiome company dedicated to improving people’s health through microbiome-targeted solutions, the first and only medical probiotics to clinically demonstrate elevated A1C and elevated blood glucose levels. , Announced today the launch of Pendulum Glucose Control. Pendulum Glucose Control is designed specifically for dietary control of type 2 diabetes, affecting approximately 30 million Americans.[1].. Managing blood sugar is the key to improving the health of people with type 2 and prediabetes. Pendulum glucose control is a medical food used under the supervision of a doctor.

“We are taking a new approach to managing type 2 diabetes via the intestinal microbiome with pendulum glucose control,” he said. Colleen Cutcliffe, Ph.D., CEO and co-founder of Pendulum Therapeutics. “Medical probiotics is a new category of probiotics that targets clinical probiotics strains with clinical efficacy in the management of certain diseases or conditions. Our patented formulation includes , A new and unique blend of prebiotics and beneficial probiotic strains, found in other probiotics on the market, and also for general “gut health” Unlike the claimed “off-the-shelf” probiotics, our medical probiotics have been clinically tested and shown to offer meaningful benefits in controlling blood glucose levels. “

People with type 2 diabetes have a lot of disruption in their metabolic processes, and their main problem is their reduced ability to metabolize fiber to manage blood sugar. Pendulum Glucose Control contains target strains of beneficial bacteria that help relieve bowel dysfunction in patients with type 2 diabetes. Identified using DNA sequencing, these new strains of butyrate, a short-chain fatty acid that plays a key role in fiber metabolism and the body’s natural ability to signal insulin production and stabilize blood sugar levels. Helps produce. In the absence of gut microbes, the fibers are not properly metabolized to butyrate and simply pass through the body. Additional benefits include strengthening the lining of the intestine, which helps prevent inflammation, and utilizing fibers to energize the colon.

“With the introduction of Pendulum glucose control, Pendulum is revolutionizing the way we manage diet management for type 2 diabetes.” David F. KrugerCertified Diabetes Nurse in the Department of Endocrinology, Diabetes, and Bone Metabolism within the MSN, APN-BC, BC-ADM, Henry Ford Health System. “Pendulum glucose control plays a unique role in restoring lost function in the intestinal microbiome and maximizing the benefits of dietary fiber to help manage healthy blood glucose levels.”

Pendulum is undergoing preclinical and clinical evaluation of the safety and metabolic effects of pendulum glucose control. In a 12-week randomized, double-blind, placebo-controlled nutrition study, pendulum glucose control reduced A1C (0.6%) and blood glucose spikes (33%) compared to placebo in patients with type 2 diabetes. Was [2]..

“As recently mentioned by the World Health Organization, the treatment and management of diabetes is even more important. [3] People with diabetes and related health complications, along with the elderly, are among the most vulnerable to severe cases of COVID-19. People who do not manage diabetes and experience blood sugar fluctuations may have a hard time eradicating viral infections, including COVID-19. “Cutcliffe points out. Recent studies also show a direct link between hyperglycemia and COVID-19 complications [4] [5]..

Pendulum Glucose Control is now available online. www.pendulumlife.com.. The company offers multiple purchasing options. $165 Monthly money back guarantee. Pendulum recognizes how important it is to provide nutritional and diabetes education support to successfully manage this condition and provides complementary nutrition consultations.

Pendulum Glucose Control is a medical food and can be taken in addition to metformin, the first line of drug therapy. It is intended for use only under the supervision of a physician as part of a comprehensive diabetes management plan. Pendulum Glucose Control is non-GMO project validated, vegan, dairy free, gluten free and capsules should be taken twice daily (both morning and evening) with food.

For more information or to purchase Pendulum Glucose Control, please visit: www.pendulumlife.com.

About pendulum treatment
Pendulum Therapeutics is the first and only microbiome company to apply the discovery of high-resolution long-read DNA sequencing to the development and commercialization of microbiome interventions for specific diseases. Its main product, Pendulum glucose controlIs the only clinically demonstrated medical probiotic that offers microbiome-mediated dietary management to help control A1C and blood glucose levels in patients with type 2 diabetes. Pendulum’s unique innovation platform allows us to identify the mechanism of action of the microbiome and quickly translate from discovery and development to human clinical validation. Pendulum was founded in 2012 by a diverse team of scientists with deep expertise in microbiology, biochemistry, computational and clinical, $57 million to date. Sequoia Capital led Series B with repeated participation from Mayo Clinic, True Ventures, Kosra Ventures, AME Cloud Ventures and others. Pendulum Therapeutics used to be based in Whole Biome. San Francisco.. For more information, please visit www.Pendulum.co..

[1] https://www.cdc.gov/diabetes/basics/type2.html

[2] A nutritional study of the Pendulum Glucose Control demonstrated a significant reduction in A1C and blood glucose levels in patients with type 2 diabetes. Randomized, double-blind, placebo-controlled, and spread across multiple sites in the United States. https://clinicaltrials.gov/ct2/show/NCT03893422?term=Whole+Biome&cond=Type+2+diabetes&cntry=US&state=US%3ACA&age=12&rank=1

[3] https://www.who.int/indonesia/news/detail/08-03-2020-knowing-the-risk-for-covid-19

[4] Guo, Weina, etc. “Diabetes is a risk factor for COVID-19 progression and prognosis.” Diabetes/Metabolism Research and Review (2020): e3319.

[5] Hill, Michael A., Christos Manzoros,and James R. Sowers.. “Commentary: COVID-19 in diabetic patients.” Metabolism (2020).

View original content and download multimedia:http://www.prnewswire.com/news-releases/pendulum-therapeutics-launches-first-medical-probiotic-for-people-with-type-2-diabetes-301070572.html

Sauce pendulum